VectorB2B will be at “Bio-Europe Spring 2021”

Vector B2B will be participating in the Bio-Europe Spring 2021 between March 22-25. Bio-Europe Spring is the European largest springtime digital partnering event with the aim of connecting the right partners in Life Sciences. It features workshops and company presentations with the main focus of providing the right environment for interaction and partnering opportunities. Participating companies will […]

Interview with Miguel Garcia

  Miguel Garcia is the co-founder and CEO of TechnoPhage, one of the companies with the highest R&D in Portugal. Miguel Garcia is also one of the promotors that envisioned a company that could provide multidisciplinary tailor-made solutions adjusted to SME Biotechs and Academia’s needs. A company that could solve complex problems by addressing the […]

Leading partner in TechnoPhage Clinical Trial

Vector B2B – Drug Development has been elected as the lead partner to manage the TechnoPhage clinical trial on Diabetic Foot Ulcers. TechnoPhage trusted Vector B2B – Drug Development to conduct the TP-102_101/REVERSE study, a Phase I/IIa Double-Blind Randomized Clinical Trial to determine the safety and tolerability of the bacteriophage cocktail TP-102 in subjects with […]

Celebrating contracts with service providers

What are the 5 main topics to have in mind when celebrating contracts with service providers? Before entering this article’s core, it is important to understand what is a services agreement. A services agreement is a binding legal document that establishes the terms and conditions of a service. When drafting this type of document, there […]